Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEEPLE: Enoxaparin vs UFH in Elective PCI
NCT00077844Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2004
- Primary completion
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of enoxaparin in coronary artery disease (CAD), sponsored by Sanofi. Started Jan 2004; status: completed.
02
Drugs
enoxaparin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00077844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077844.